Lexaptepid pegol

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLexaptepid pegol
Drug Alias Name培戈-来萨替哌lexaptepid pegol培雷沙泰派lexaptepidum pegolumNOX-H94
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionHepcidin inhibitors
TargetsHepcidin
Therapy Area/IndicationsInflammationChronic DiseaseAnemia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaRomaniaNetherlands +[7] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNoxxon Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTme Pharma AG
Active IndicationsN/A
Inactive IndicationsInflammationChronic DiseaseAnemia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A